Article Text

Download PDFPDF
Hyperinsulinaemic hypoglycaemia
  1. R R Kapoor1,
  2. S E Flanagan2,
  3. C James1,
  4. J Shield3,
  5. S Ellard2,
  6. K Hussain1
  1. 1
    Institute of Child Health, University College London, London, UK
  2. 2
    Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, UK
  3. 3
    Department of Child Health, Bristol Royal Hospital for Children, Bristol, UK
  1. K Hussain, Developmental Endocrinology Research Group, Molecular Genetics Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK; K.Hussain{at}


Hyperinsulinaemic hypoglycaemia (HH) occurs as a consequence of unregulated insulin secretion from pancreatic β cells. In the newborn period it is the most common cause of severe and persistent hypoglycaemia. As HH is a major risk factor for brain injury and subsequent neurodevelopment handicap, the identification, rapid diagnosis and prompt management of patients with HH is essential if brain damage is to be avoided. Advances in molecular genetics, radiological imaging techniques (such as fluorine-18 L-3, 4-dihydroxyphenylalanine positron emission tomography (18FDOPA-PET) scanning) and laparoscopic surgery have completely changed the clinical approach to infants with the severe congenital forms of HH. This review gives an outline of the clinical presentation, the diagnostic cascade, the underlying molecular mechanisms and the management of HH with a particular focus on congenital forms of hyperinsulinism.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None declared.